Comparison of clinical efficacy and safety of weilikang and domperidone in treatment of reflux esophagitis
- VernacularTitle:胃力康与多潘立酮治疗反流性食管炎临床疗效和安全性比较
- Author:
Zanxiong CHEN
;
- Publication Type:Journal Article
- Keywords:
pharmacodynamics;
weilikang;
domperidone;
reflux esophagitis
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2000;0(02):-
- CountryChina
- Language:Chinese
-
Abstract:
AIM: To compare the clinical efficacy and safety of weilikang and domperidone in treatment of reflux esophagitis. METHODS: 80 cases of patients with reflux esophagitis were divided into two groups: one group patients were treated with Weilikang 10 g, po, tid; the other group ones was given domperidone, 10 mg, po, tid. The period of treatment all was 6 weeks. RESULTS: After 6 weeks, the total efficacy rates of weilikang and domperidone were 85.0 % and 60.0 % (P
